Extracellular Vesicle-Based Vaccines
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (1 September 2022) | Viewed by 3361
Special Issue Editors
Interests: extracellular vesicles; viral particles; nanoparticles; immunotherapy; vaccine
Special Issue Information
Dear Colleagues,
We are slowly progressing from a pandemic to the “new normal” that came about due to the help of novel vaccine technologies.
We would like to invite you to share your ideas concerning recent developments that came about during this period focusing on extracellular vesicles (membranous and non-membranous nanovesicles), viral particles, and synthetic particles able to elicit a preventive immune response.
In this Special Issue, we will bundle studies and reviews that elucidate the use of extracellular vesicles for vaccination purposes, focusing on their use as a multicargo carrier that will be important in the development of next-generation vaccines.
Dr. Koen Breyne
Dr. Taral Rameshchand Lunavat
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccination
- extracellular vesicles
- vRNAs
- vProteins
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
